The global market for Recombinant Human Follicle-stimulating Hormone was valued at US$ 1154 million in the year 2024 and is projected to reach a revised size of US$ 1680 million by 2031, growing at a CAGR of 5.6% during the forecast period.

Recombinant Human Follicle-stimulating Hormone Market

Recombinant Human Follicle-Stimulating Hormone (r-hFSH) is a biotechnologically produced hormone that plays a crucial role in the human reproductive system. It is a synthetic form of the naturally occurring follicle-stimulating hormone (FSH), which is produced by the anterior pituitary gland in the brain. FSH is essential for the regulation of the female and male reproductive systems and is involved in processes like ovarian follicle development, sperm production, and the maturation of reproductive cells.

Increasing Demand for Assisted Reproductive Technologies (ART): The growing acceptance of ART, including in vitro fertilization (IVF), is driving the demand for r-hFSH. ART is used by individuals and couples to address infertility issues, and r-hFSH plays a vital role in controlled ovarian stimulation.

Advancements in ART Procedures: Ongoing advancements in ART procedures are leading to increased use of r-hFSH. These procedures continue to improve success rates, which further fuels demand.

Expanded Indications: The use of r-hFSH is being explored for a broader range of indications, including for individuals with specific hormonal imbalances or other medical conditions that affect reproductive health.

Personalized Medicine: Tailoring treatment regimens to individual patients is gaining importance. Clinicians are increasingly using r-hFSH in personalized fertility treatment plans, optimizing the chances of success while minimizing side effects.

Global Expansion: The use of r-hFSH is expanding globally as countries invest in reproductive healthcare infrastructure. Emerging markets are showing increased demand for fertility treatments and related products.

This report aims to provide a comprehensive presentation of the global market for Recombinant Human Follicle-stimulating Hormone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Follicle-stimulating Hormone.

The Recombinant Human Follicle-stimulating Hormone market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Human Follicle-stimulating Hormone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Recombinant Human Follicle-stimulating Hormone companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Recombinant Human Follicle-stimulating Hormone Market Report

Report Metric	Details
Report Name	Recombinant Human Follicle-stimulating Hormone Market
Accounted market size in year	US$ 1154 million
Forecasted market size in 2031	US$ 1680 million
CAGR	5.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	75IU 150IU Others
Segment by Application	Infertility Treatment Assisted Reproductive Technology
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck, Ferring, Livzon, Gedeon Richter, GenSci, Teva, ChangChun High & New Technology, ABL, Scripps Laboratories, Alphamab Oncology, Hunan Jingfeng Pharmaceutical, Qilu Pharmaceutical, Beijing SL Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Recombinant Human Follicle-stimulating Hormone company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Recombinant Human Follicle-stimulating Hormone Market growing?

Ans: The Recombinant Human Follicle-stimulating Hormone Market witnessing a CAGR of 5.6% during the forecast period 2025-2031.

What is the Recombinant Human Follicle-stimulating Hormone Market size in 2031?

Ans: The Recombinant Human Follicle-stimulating Hormone Market size in 2031 will be US$ 1680 million.

Who are the main players in the Recombinant Human Follicle-stimulating Hormone Market report?

Ans: The main players in the Recombinant Human Follicle-stimulating Hormone Market are Merck, Ferring, Livzon, Gedeon Richter, GenSci, Teva, ChangChun High & New Technology, ABL, Scripps Laboratories, Alphamab Oncology, Hunan Jingfeng Pharmaceutical, Qilu Pharmaceutical, Beijing SL Pharmaceutical

What are the Application segmentation covered in the Recombinant Human Follicle-stimulating Hormone Market report?

Ans: The Applications covered in the Recombinant Human Follicle-stimulating Hormone Market report are Infertility Treatment, Assisted Reproductive Technology

What are the Type segmentation covered in the Recombinant Human Follicle-stimulating Hormone Market report?

Ans: The Types covered in the Recombinant Human Follicle-stimulating Hormone Market report are 75IU, 150IU, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Recombinant Human Follicle-stimulating Hormone Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 75IU

1.2.3 150IU

1.2.4 Others

1.3 Market by Application

1.3.1 Global Recombinant Human Follicle-stimulating Hormone Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Infertility Treatment

1.3.3 Assisted Reproductive Technology

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Recombinant Human Follicle-stimulating Hormone Market Perspective (2020-2031)

2.2 Global Recombinant Human Follicle-stimulating Hormone Growth Trends by Region

2.2.1 Global Recombinant Human Follicle-stimulating Hormone Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Recombinant Human Follicle-stimulating Hormone Historic Market Size by Region (2020-2025)

2.2.3 Recombinant Human Follicle-stimulating Hormone Forecasted Market Size by Region (2026-2031)

2.3 Recombinant Human Follicle-stimulating Hormone Market Dynamics

2.3.1 Recombinant Human Follicle-stimulating Hormone Industry Trends

2.3.2 Recombinant Human Follicle-stimulating Hormone Market Drivers

2.3.3 Recombinant Human Follicle-stimulating Hormone Market Challenges

2.3.4 Recombinant Human Follicle-stimulating Hormone Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Recombinant Human Follicle-stimulating Hormone Players by Revenue

3.1.1 Global Top Recombinant Human Follicle-stimulating Hormone Players by Revenue (2020-2025)

3.1.2 Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Players (2020-2025)

3.2 Global Recombinant Human Follicle-stimulating Hormone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Recombinant Human Follicle-stimulating Hormone Revenue

3.4 Global Recombinant Human Follicle-stimulating Hormone Market Concentration Ratio

3.4.1 Global Recombinant Human Follicle-stimulating Hormone Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Recombinant Human Follicle-stimulating Hormone Revenue in 2024

3.5 Global Key Players of Recombinant Human Follicle-stimulating Hormone Head office and Area Served

3.6 Global Key Players of Recombinant Human Follicle-stimulating Hormone, Product and Application

3.7 Global Key Players of Recombinant Human Follicle-stimulating Hormone, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Recombinant Human Follicle-stimulating Hormone Breakdown Data by Type

4.1 Global Recombinant Human Follicle-stimulating Hormone Historic Market Size by Type (2020-2025)

4.2 Global Recombinant Human Follicle-stimulating Hormone Forecasted Market Size by Type (2026-2031)

5 Recombinant Human Follicle-stimulating Hormone Breakdown Data by Application

5.1 Global Recombinant Human Follicle-stimulating Hormone Historic Market Size by Application (2020-2025)

5.2 Global Recombinant Human Follicle-stimulating Hormone Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Recombinant Human Follicle-stimulating Hormone Market Size (2020-2031)

6.2 North America Recombinant Human Follicle-stimulating Hormone Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Recombinant Human Follicle-stimulating Hormone Market Size by Country (2020-2025)

6.4 North America Recombinant Human Follicle-stimulating Hormone Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Recombinant Human Follicle-stimulating Hormone Market Size (2020-2031)

7.2 Europe Recombinant Human Follicle-stimulating Hormone Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Recombinant Human Follicle-stimulating Hormone Market Size by Country (2020-2025)

7.4 Europe Recombinant Human Follicle-stimulating Hormone Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Recombinant Human Follicle-stimulating Hormone Market Size (2020-2031)

8.2 Asia-Pacific Recombinant Human Follicle-stimulating Hormone Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Recombinant Human Follicle-stimulating Hormone Market Size by Region (2020-2025)

8.4 Asia-Pacific Recombinant Human Follicle-stimulating Hormone Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Recombinant Human Follicle-stimulating Hormone Market Size (2020-2031)

9.2 Latin America Recombinant Human Follicle-stimulating Hormone Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Recombinant Human Follicle-stimulating Hormone Market Size by Country (2020-2025)

9.4 Latin America Recombinant Human Follicle-stimulating Hormone Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Size (2020-2031)

10.2 Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Size by Country (2020-2025)

10.4 Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Merck

11.1.1 Merck Company Details

11.1.2 Merck Business Overview

11.1.3 Merck Recombinant Human Follicle-stimulating Hormone Introduction

11.1.4 Merck Revenue in Recombinant Human Follicle-stimulating Hormone Business (2020-2025)

11.1.5 Merck Recent Development

11.2 Ferring

11.2.1 Ferring Company Details

11.2.2 Ferring Business Overview

11.2.3 Ferring Recombinant Human Follicle-stimulating Hormone Introduction

11.2.4 Ferring Revenue in Recombinant Human Follicle-stimulating Hormone Business (2020-2025)

11.2.5 Ferring Recent Development

11.3 Livzon

11.3.1 Livzon Company Details

11.3.2 Livzon Business Overview

11.3.3 Livzon Recombinant Human Follicle-stimulating Hormone Introduction

11.3.4 Livzon Revenue in Recombinant Human Follicle-stimulating Hormone Business (2020-2025)

11.3.5 Livzon Recent Development

11.4 Gedeon Richter

11.4.1 Gedeon Richter Company Details

11.4.2 Gedeon Richter Business Overview

11.4.3 Gedeon Richter Recombinant Human Follicle-stimulating Hormone Introduction

11.4.4 Gedeon Richter Revenue in Recombinant Human Follicle-stimulating Hormone Business (2020-2025)

11.4.5 Gedeon Richter Recent Development

11.5 GenSci

11.5.1 GenSci Company Details

11.5.2 GenSci Business Overview

11.5.3 GenSci Recombinant Human Follicle-stimulating Hormone Introduction

11.5.4 GenSci Revenue in Recombinant Human Follicle-stimulating Hormone Business (2020-2025)

11.5.5 GenSci Recent Development

11.6 Teva

11.6.1 Teva Company Details

11.6.2 Teva Business Overview

11.6.3 Teva Recombinant Human Follicle-stimulating Hormone Introduction

11.6.4 Teva Revenue in Recombinant Human Follicle-stimulating Hormone Business (2020-2025)

11.6.5 Teva Recent Development

11.7 ChangChun High & New Technology

11.7.1 ChangChun High & New Technology Company Details

11.7.2 ChangChun High & New Technology Business Overview

11.7.3 ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Introduction

11.7.4 ChangChun High & New Technology Revenue in Recombinant Human Follicle-stimulating Hormone Business (2020-2025)

11.7.5 ChangChun High & New Technology Recent Development

11.8 ABL

11.8.1 ABL Company Details

11.8.2 ABL Business Overview

11.8.3 ABL Recombinant Human Follicle-stimulating Hormone Introduction

11.8.4 ABL Revenue in Recombinant Human Follicle-stimulating Hormone Business (2020-2025)

11.8.5 ABL Recent Development

11.9 Scripps Laboratories

11.9.1 Scripps Laboratories Company Details

11.9.2 Scripps Laboratories Business Overview

11.9.3 Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Introduction

11.9.4 Scripps Laboratories Revenue in Recombinant Human Follicle-stimulating Hormone Business (2020-2025)

11.9.5 Scripps Laboratories Recent Development

11.10 Alphamab Oncology

11.10.1 Alphamab Oncology Company Details

11.10.2 Alphamab Oncology Business Overview

11.10.3 Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Introduction

11.10.4 Alphamab Oncology Revenue in Recombinant Human Follicle-stimulating Hormone Business (2020-2025)

11.10.5 Alphamab Oncology Recent Development

11.11 Hunan Jingfeng Pharmaceutical

11.11.1 Hunan Jingfeng Pharmaceutical Company Details

11.11.2 Hunan Jingfeng Pharmaceutical Business Overview

11.11.3 Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Introduction

11.11.4 Hunan Jingfeng Pharmaceutical Revenue in Recombinant Human Follicle-stimulating Hormone Business (2020-2025)

11.11.5 Hunan Jingfeng Pharmaceutical Recent Development

11.12 Qilu Pharmaceutical

11.12.1 Qilu Pharmaceutical Company Details

11.12.2 Qilu Pharmaceutical Business Overview

11.12.3 Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Introduction

11.12.4 Qilu Pharmaceutical Revenue in Recombinant Human Follicle-stimulating Hormone Business (2020-2025)

11.12.5 Qilu Pharmaceutical Recent Development

11.13 Beijing SL Pharmaceutical

11.13.1 Beijing SL Pharmaceutical Company Details

11.13.2 Beijing SL Pharmaceutical Business Overview

11.13.3 Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Introduction

11.13.4 Beijing SL Pharmaceutical Revenue in Recombinant Human Follicle-stimulating Hormone Business (2020-2025)

11.13.5 Beijing SL Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

ChangChun High & New Technology

Beijing SL Pharmaceutical

Hunan Jingfeng Pharmaceutical

List of Tables

Table 1. Global Recombinant Human Follicle-stimulating Hormone Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of 75IU

Table 3. Key Players of 150IU

Table 4. Key Players of Others

Table 5. Global Recombinant Human Follicle-stimulating Hormone Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Recombinant Human Follicle-stimulating Hormone Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Recombinant Human Follicle-stimulating Hormone Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Recombinant Human Follicle-stimulating Hormone Market Share by Region (2020-2025)

Table 9. Global Recombinant Human Follicle-stimulating Hormone Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Recombinant Human Follicle-stimulating Hormone Market Share by Region (2026-2031)

Table 11. Recombinant Human Follicle-stimulating Hormone Market Trends

Table 12. Recombinant Human Follicle-stimulating Hormone Market Drivers

Table 13. Recombinant Human Follicle-stimulating Hormone Market Challenges

Table 14. Recombinant Human Follicle-stimulating Hormone Market Restraints

Table 15. Global Recombinant Human Follicle-stimulating Hormone Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Recombinant Human Follicle-stimulating Hormone Market Share by Players (2020-2025)

Table 17. Global Top Recombinant Human Follicle-stimulating Hormone Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Follicle-stimulating Hormone as of 2024)

Table 18. Ranking of Global Top Recombinant Human Follicle-stimulating Hormone Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Recombinant Human Follicle-stimulating Hormone Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Recombinant Human Follicle-stimulating Hormone, Headquarters and Area Served

Table 21. Global Key Players of Recombinant Human Follicle-stimulating Hormone, Product and Application

Table 22. Global Key Players of Recombinant Human Follicle-stimulating Hormone, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Recombinant Human Follicle-stimulating Hormone Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Type (2020-2025)

Table 26. Global Recombinant Human Follicle-stimulating Hormone Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Type (2026-2031)

Table 28. Global Recombinant Human Follicle-stimulating Hormone Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Application (2020-2025)

Table 30. Global Recombinant Human Follicle-stimulating Hormone Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Application (2026-2031)

Table 32. North America Recombinant Human Follicle-stimulating Hormone Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Recombinant Human Follicle-stimulating Hormone Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Recombinant Human Follicle-stimulating Hormone Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Recombinant Human Follicle-stimulating Hormone Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Recombinant Human Follicle-stimulating Hormone Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Recombinant Human Follicle-stimulating Hormone Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Recombinant Human Follicle-stimulating Hormone Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Recombinant Human Follicle-stimulating Hormone Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Recombinant Human Follicle-stimulating Hormone Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Size by Country (2026-2031) & (US$ Million)

Table 47. Merck Company Details

Table 48. Merck Business Overview

Table 49. Merck Recombinant Human Follicle-stimulating Hormone Product

Table 50. Merck Revenue in Recombinant Human Follicle-stimulating Hormone Business (2020-2025) & (US$ Million)

Table 51. Merck Recent Development

Table 52. Ferring Company Details

Table 53. Ferring Business Overview

Table 54. Ferring Recombinant Human Follicle-stimulating Hormone Product

Table 55. Ferring Revenue in Recombinant Human Follicle-stimulating Hormone Business (2020-2025) & (US$ Million)

Table 56. Ferring Recent Development

Table 57. Livzon Company Details

Table 58. Livzon Business Overview

Table 59. Livzon Recombinant Human Follicle-stimulating Hormone Product

Table 60. Livzon Revenue in Recombinant Human Follicle-stimulating Hormone Business (2020-2025) & (US$ Million)

Table 61. Livzon Recent Development

Table 62. Gedeon Richter Company Details

Table 63. Gedeon Richter Business Overview

Table 64. Gedeon Richter Recombinant Human Follicle-stimulating Hormone Product

Table 65. Gedeon Richter Revenue in Recombinant Human Follicle-stimulating Hormone Business (2020-2025) & (US$ Million)

Table 66. Gedeon Richter Recent Development

Table 67. GenSci Company Details

Table 68. GenSci Business Overview

Table 69. GenSci Recombinant Human Follicle-stimulating Hormone Product

Table 70. GenSci Revenue in Recombinant Human Follicle-stimulating Hormone Business (2020-2025) & (US$ Million)

Table 71. GenSci Recent Development

Table 72. Teva Company Details

Table 73. Teva Business Overview

Table 74. Teva Recombinant Human Follicle-stimulating Hormone Product

Table 75. Teva Revenue in Recombinant Human Follicle-stimulating Hormone Business (2020-2025) & (US$ Million)

Table 76. Teva Recent Development

Table 77. ChangChun High & New Technology Company Details

Table 78. ChangChun High & New Technology Business Overview

Table 79. ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Product

Table 80. ChangChun High & New Technology Revenue in Recombinant Human Follicle-stimulating Hormone Business (2020-2025) & (US$ Million)

Table 81. ChangChun High & New Technology Recent Development

Table 82. ABL Company Details

Table 83. ABL Business Overview

Table 84. ABL Recombinant Human Follicle-stimulating Hormone Product

Table 85. ABL Revenue in Recombinant Human Follicle-stimulating Hormone Business (2020-2025) & (US$ Million)

Table 86. ABL Recent Development

Table 87. Scripps Laboratories Company Details

Table 88. Scripps Laboratories Business Overview

Table 89. Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Product

Table 90. Scripps Laboratories Revenue in Recombinant Human Follicle-stimulating Hormone Business (2020-2025) & (US$ Million)

Table 91. Scripps Laboratories Recent Development

Table 92. Alphamab Oncology Company Details

Table 93. Alphamab Oncology Business Overview

Table 94. Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Product

Table 95. Alphamab Oncology Revenue in Recombinant Human Follicle-stimulating Hormone Business (2020-2025) & (US$ Million)

Table 96. Alphamab Oncology Recent Development

Table 97. Hunan Jingfeng Pharmaceutical Company Details

Table 98. Hunan Jingfeng Pharmaceutical Business Overview

Table 99. Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product

Table 100. Hunan Jingfeng Pharmaceutical Revenue in Recombinant Human Follicle-stimulating Hormone Business (2020-2025) & (US$ Million)

Table 101. Hunan Jingfeng Pharmaceutical Recent Development

Table 102. Qilu Pharmaceutical Company Details

Table 103. Qilu Pharmaceutical Business Overview

Table 104. Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product

Table 105. Qilu Pharmaceutical Revenue in Recombinant Human Follicle-stimulating Hormone Business (2020-2025) & (US$ Million)

Table 106. Qilu Pharmaceutical Recent Development

Table 107. Beijing SL Pharmaceutical Company Details

Table 108. Beijing SL Pharmaceutical Business Overview

Table 109. Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product

Table 110. Beijing SL Pharmaceutical Revenue in Recombinant Human Follicle-stimulating Hormone Business (2020-2025) & (US$ Million)

Table 111. Beijing SL Pharmaceutical Recent Development

Table 112. Research Programs/Design for This Report

Table 113. Key Data Information from Secondary Sources

Table 114. Key Data Information from Primary Sources

Table 115. Authors List of This Report

List of Figures

Figure 1. Recombinant Human Follicle-stimulating Hormone Picture

Figure 2. Global Recombinant Human Follicle-stimulating Hormone Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Recombinant Human Follicle-stimulating Hormone Market Share by Type: 2024 VS 2031

Figure 4. 75IU Features

Figure 5. 150IU Features

Figure 6. Others Features

Figure 7. Global Recombinant Human Follicle-stimulating Hormone Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Recombinant Human Follicle-stimulating Hormone Market Share by Application: 2024 VS 2031

Figure 9. Infertility Treatment Case Studies

Figure 10. Assisted Reproductive Technology Case Studies

Figure 11. Recombinant Human Follicle-stimulating Hormone Report Years Considered

Figure 12. Global Recombinant Human Follicle-stimulating Hormone Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Recombinant Human Follicle-stimulating Hormone Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Recombinant Human Follicle-stimulating Hormone Market Share by Region: 2024 VS 2031

Figure 15. Global Recombinant Human Follicle-stimulating Hormone Market Share by Players in 2024

Figure 16. Global Top Recombinant Human Follicle-stimulating Hormone Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Follicle-stimulating Hormone as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Recombinant Human Follicle-stimulating Hormone Revenue in 2024

Figure 18. North America Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Recombinant Human Follicle-stimulating Hormone Market Share by Country (2020-2031)

Figure 20. United States Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Recombinant Human Follicle-stimulating Hormone Market Share by Country (2020-2031)

Figure 24. Germany Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Market Share by Region (2020-2031)

Figure 32. China Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Recombinant Human Follicle-stimulating Hormone Market Share by Country (2020-2031)

Figure 40. Mexico Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Share by Country (2020-2031)

Figure 44. Turkey Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Merck Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2020-2025)

Figure 48. Ferring Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2020-2025)

Figure 49. Livzon Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2020-2025)

Figure 50. Gedeon Richter Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2020-2025)

Figure 51. GenSci Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2020-2025)

Figure 52. Teva Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2020-2025)

Figure 53. ChangChun High & New Technology Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2020-2025)

Figure 54. ABL Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2020-2025)

Figure 55. Scripps Laboratories Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2020-2025)

Figure 56. Alphamab Oncology Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2020-2025)

Figure 57. Hunan Jingfeng Pharmaceutical Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2020-2025)

Figure 58. Qilu Pharmaceutical Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2020-2025)

Figure 59. Beijing SL Pharmaceutical Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Chrysalis Oil Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26N13078

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Eucommia Ulmoides Extract Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3L13782

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global MRSA Drugs Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26S13718

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Ferrous Citrate Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-16S12875

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions